Shares of FIGS, Inc. (FIGS) surged 12.37% on Thursday following the release of the company's impressive second-quarter financial results and an upward revision of its full-year guidance. The healthcare apparel maker demonstrated strong performance across key metrics, surpassing analyst expectations and showcasing robust growth in its core business segments.

FIGS reported adjusted earnings per share of $0.04 for the second quarter, doubling the analyst estimate of $0.02. The company's revenue also beat expectations, reaching $152.6 million compared to the projected $144.3 million. This 5.8% year-over-year increase in revenue was primarily attributed to higher order volumes from both new and existing customers, as well as an increase in average order value.

The company's strong performance was evident across various segments. Scrubwear net revenues rose by 7.7% year-over-year, while international net revenues saw a significant boost of 19.8%. FIGS CEO Trina Spear noted that the company is moving past the COVID-19 overhang towards more normalized purchasing and replenishment trends, which is expected to drive further top-line growth. In light of these positive results, FIGS raised its full-year guidance, now projecting low-single-digit revenue growth for 2025, up from its previous forecast of a low-single-digit decline. The company also increased its adjusted EBITDA margin outlook to 8.5%-9% from the previous 7.5%-8.5%. This optimistic outlook, coupled with the strong Q2 performance, has clearly resonated with investors, driving the significant stock price increase.